Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Schuuring

Showing results (131-140 of 210) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|December 1, 2021
Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survivalMenno Tamminga, Kiki C Andree, Hilda van den Bos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2020
Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibitionJorianne Boers, Clasina M Venema, Erik F J de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2020
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutationPei Meng, Bart Koopman, Klaas Kok, et al.
Human Pathology|November 17, 2010
The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancerJasper J H Eijsink, Maartje G Noordhuis, Klaske A ten Hoor, et al.
Epigenetics|April 2, 2015
Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugsChristian Huisman, Monique G P van der Wijst, Fahimeh Falahi, et al.
Head & Neck|May 19, 2021
Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mmKoos Boeve, Mirjam F Mastik, Lorian Slagter-Menkema, et al.
Genes, Chromosomes & Cancer|March 23, 2004
Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regionsEugenia Haralambieva, Ed Schuuring, Stefano Rosati, et al.
The Laryngoscope|October 30, 2013
Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapyJan E Wachters, Michiel L Schrijvers, Lorian Slagter-Menkema, et al.
Cancers|April 11, 2020
Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch<sup>®</sup> and ISETMenno Tamminga, Kiki C Andree, T Jeroen N Hiltermann, et al.
The Laryngoscope|March 18, 2017
Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapyJan E Wachters, Michiel L Schrijvers, Lorian Slagter-Menkema, et al.
Pageof 21

Showing results (131-140 of 210) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|December 1, 2021
Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survivalMenno Tamminga, Kiki C Andree, Hilda van den Bos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2020
Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibitionJorianne Boers, Clasina M Venema, Erik F J de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2020
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutationPei Meng, Bart Koopman, Klaas Kok, et al.
Human Pathology|November 17, 2010
The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancerJasper J H Eijsink, Maartje G Noordhuis, Klaske A ten Hoor, et al.
Epigenetics|April 2, 2015
Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugsChristian Huisman, Monique G P van der Wijst, Fahimeh Falahi, et al.
Head & Neck|May 19, 2021
Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mmKoos Boeve, Mirjam F Mastik, Lorian Slagter-Menkema, et al.
Genes, Chromosomes & Cancer|March 23, 2004
Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regionsEugenia Haralambieva, Ed Schuuring, Stefano Rosati, et al.
The Laryngoscope|October 30, 2013
Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapyJan E Wachters, Michiel L Schrijvers, Lorian Slagter-Menkema, et al.
Cancers|April 11, 2020
Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch<sup>®</sup> and ISETMenno Tamminga, Kiki C Andree, T Jeroen N Hiltermann, et al.
The Laryngoscope|March 18, 2017
Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapyJan E Wachters, Michiel L Schrijvers, Lorian Slagter-Menkema, et al.
Pageof 21